Increasing prevalence of skin and genetic disorders, rising cases of skin cancer are major drivers for the market growth. Moreover, rising funding for new drug development and clinical trials are leading the growth for the market. Additionally, growing awareness of diseases, technological advancement, and increasing healthcare spending are major driving forces of global isotretinoin drugs market. Government initiatives and FDA approvals are also important factors for the market growth. However some factors like side effects of drugs and product recall are affecting the growth of global isotretinoin drugs market.
The Global Isotretinoin drugs market is growing at the CAGR of ~3.2% during the forecast period and expected to reach USD 1567.1 million by 2023.
Key Players for Global Isotretinoin drugs Market:
Some of the key players in this market are: Akorn, Inc. (US), Dr. Reddy’s Laboratories Ltd. (India), F. Hoffmann-La Roche Ltd (Switzerland), Mylan N.V. (US), Ranbaxy Laboratories Inc, a SUN PHARMA company. (India), Teva Pharmaceuticals USA, Inc (US), and others
Segments:
Global Isotretinoin drugs Market has been segmented on the basis of application which comprise severe acne, Neuroblastoma, Cutaneous T-Cell Lymphomas, harlequin ichthyosis, xeroderma pigmentosum, fibrodysplasia ossificans progressiva, Squamous cell skin cancers, and others. Severe acne is further sub-segmented into Nodulocystic acne, Acne conglobate, Acne fulminans, Gram negative folliculitis, and others. Neuroblastoma is further sub-segmented into Stage 1, Stage 2A, Stage 2B, Stage 3, Stage 4, Stage 4S, and others. Cutaneous T-Cell Lymphomas is further sub segmented into Mycosis fungoides, Pagetoid reticulosis, Lymphomatoid papulosis, Granulomatous slack skin, and others. Xeroderma pigmentosum is further sub-segmented into group A, group B, group C, group D, and others. On the basis of end user, the market is segmented into Hospitals, Research laboratories, and others.
Request Customization
Get a Sample
Get a Sample
Request Customization